<DOC>
	<DOCNO>NCT00449501</DOCNO>
	<brief_summary>The purpose study demonstrate whether subject respond similarly Onset Effect Questionnaire ( OEQ ) administer pre-dose versus post-dose , receive SYMBICORT® pMDI 80/4.5 μg x 2 actuation twice daily budesonide HFA pMDI 80 μg x 2 actuation twice daily .</brief_summary>
	<brief_title>A Two-week Study Assessing Onset Effect Questionnaire Administered Pre-dose Versus Post-dose Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Male Female , &gt; 18 year age Mild moderate asthma require treatment inhale corticosteroid Diagnosis asthma least 6 month Subjects require treatment systemic corticosteroid ( e.g. , oral , parenteral , ocular ) Subjects severe asthma , judge investigator Any significant disease disorder may jeopardize subject 's safety</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Mild Asthma</keyword>
	<keyword>Moderate Asthma</keyword>
</DOC>